Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B9436-50 50 µg (0.5 mg/ml) $485 
TGFBR1 / ALK5 Antibody - Anti-TGFBR1 / ALK5 antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
TGFBR1 / ALK5 Antibody - TGFBR1 antibody (0.1 ug/ml) staining of Rat Liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
TGFBR1 / ALK5 Antibody - Anti-TGFBR1 / ALK5 antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
TGFBR1 / ALK5 Antibody - TGFBR1 antibody (0.1 ug/ml) staining of Rat Liver lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
1 of 2
2 of 2

PathPlus™ Polyclonal Goat anti‑Human TGFBR1 / ALK5 Antibody (aa50‑63, IHC, WB) LS‑B9436

PathPlus™ Polyclonal Goat anti‑Human TGFBR1 / ALK5 Antibody (aa50‑63, IHC, WB) LS‑B9436

Note: This antibody replaces LS-C154867
Antibody:
TGFBR1 / ALK5 Goat anti-Human Polyclonal (aa50-63) Antibody
Application:
IHC, IHC-P, WB, Peptide-ELISA
Reactivity:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Horse, Rabbit
Format:
Unconjugated, Unmodified
Price
Catalog Number
$485
LS-B9436-50
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
TGFBR1 / ALK5 Goat anti-Human Polyclonal (aa50-63) Antibody
Application:
IHC, IHC-P, WB, Peptide-ELISA
Reactivity:
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Horse, Rabbit
Format:
Unconjugated, Unmodified

Specifications

Description
TGFBR1 (ALK5) is a transcription growth factor beta receptor that works with TGFB1 and other TGF-beta ligands to regulate development of the central nervous system, adult neurogenesis, neuronal survival and protection, and astrocyte differentiation. In neurons and in endothelial cells, TGFBR1 induces the phosphorylation of SMAD2 and SMAD3 which in turn modulate nuclear gene expression. Mutations in TGFBR1 are correlated with Loeys-Dietz aortic aneurysm syndrome (LDS). In immunohistochemistry, TGFBR1 has cytoplasmic and membranous positivity in the brain, lung, gastrointestinal tissues, liver, kidney, reproductive tissues, muscle and appendix. References: Int J Dev Neurosci. 2005 Aug;23(5):413-24, PMID: 15936920; Int J Mol Sci. 2012; 13(7): 8219–8258, PMID: 22942700; Cell Signal. 2018 Dec;52:112-120, PMID: 30184463; Cell Signal. 2018 Dec;52:112-120, PMID: 30184463; Nat Neurosci. 2014 Jul;17(7):943-52, PMID: 24859199
Target
Human TGFBR1 / ALK5
Synonyms
TGFBR1 | AAT5 | ACVRLK4 | ALK-5 | ALK5 | Activin receptor-like kinase 5 | LDS1A | LDS2A | MSSE | SKR4 | TGF beta receptor I | TGF-beta receptor type-1 | TGF-beta type I receptor | TbetaR-I | TGFR-1 | TGF-beta receptor type I
Host
Goat
Reactivity
Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Horse, Rabbit (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Modifications
Unmodified
Immunogen
Peptide with sequence TDGLCFVSVTETTD, from the internal region of the protein sequence according to NP_004603.1NP_001124388.1.
Epitope
aa50-63
Specificity
Human TGFBR1. This antibody is expected to recognize both reported isoforms (NP_004603.1; NP_001124388.1). The immunizing peptide represents part of a potential extracellular domain.
Applications
  • IHC
  • IHC - Paraffin (5 µg/ml)
  • Western blot (0.1 - 0.3 µg/ml)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:64000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
Peptide ELISA: antibody detection limit dilution 1:64000. Western blot: Approx 55kD band observed in Rat Liver lysates (calculated MW of 55.6kD according to Rat NP_036907.2). Recommended concentration: 0.1-0.3 ug/ml.
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About TGFBR1 / ALK5
P36897 NM_004612 NP_004603.1

Validation

TGFBR1 / ALK5 Antibody - Anti-TGFBR1 / ALK5 antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Anti-TGFBR1 / ALK5 antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.
Anti-TGFBR1 / ALK5 antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.

LSBio Ratings

PathPlus™ TGFBR1 / ALK5 Antibody (aa50-63) for IHC, WB/Western LS-B9436 has an LSBio Rating of
Laboratory Validation Score (5)

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/17/2024